SG11202107005YA - Genetic marker for helicobacter pylori-associated disease - Google Patents

Genetic marker for helicobacter pylori-associated disease

Info

Publication number
SG11202107005YA
SG11202107005YA SG11202107005YA SG11202107005YA SG11202107005YA SG 11202107005Y A SG11202107005Y A SG 11202107005YA SG 11202107005Y A SG11202107005Y A SG 11202107005YA SG 11202107005Y A SG11202107005Y A SG 11202107005YA SG 11202107005Y A SG11202107005Y A SG 11202107005YA
Authority
SG
Singapore
Prior art keywords
helicobacter pylori
genetic marker
associated disease
disease
genetic
Prior art date
Application number
SG11202107005YA
Other languages
English (en)
Inventor
Dong Yun Lee
Seung Hye Choi
Ji Young Oh
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of SG11202107005YA publication Critical patent/SG11202107005YA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y404/00—Carbon-sulfur lyases (4.4)
    • C12Y404/01—Carbon-sulfur lyases (4.4.1)
    • C12Y404/01001—Cystathionine gamma-lyase (4.4.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG11202107005YA 2018-12-28 2019-12-27 Genetic marker for helicobacter pylori-associated disease SG11202107005YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180171846A KR102637908B1 (ko) 2018-12-28 2018-12-28 헬리코박터 파일로리 연관 질환에 대한 유전자 마커
PCT/KR2019/018607 WO2020139021A1 (ko) 2018-12-28 2019-12-27 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Publications (1)

Publication Number Publication Date
SG11202107005YA true SG11202107005YA (en) 2021-07-29

Family

ID=71129227

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202107005YA SG11202107005YA (en) 2018-12-28 2019-12-27 Genetic marker for helicobacter pylori-associated disease

Country Status (10)

Country Link
US (1) US20220064734A1 (zh)
EP (1) EP3904534A4 (zh)
JP (1) JP7374196B2 (zh)
KR (1) KR102637908B1 (zh)
CN (1) CN113490752A (zh)
AU (1) AU2019416610B2 (zh)
CA (1) CA3125106A1 (zh)
SG (1) SG11202107005YA (zh)
TW (1) TWI754201B (zh)
WO (1) WO2020139021A1 (zh)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856094A (en) * 1995-05-12 1999-01-05 The Johns Hopkins University School Of Medicine Method of detection of neoplastic cells
US5989885A (en) * 1997-01-10 1999-11-23 Myriad Genetics, Inc. Specific mutations of map kinase 4 (MKK4) in human tumor cell lines identify it as a tumor suppressor in various types of cancer
KR100306587B1 (ko) 1998-11-19 2001-11-30 이종욱 헬리코박터파이로리감염의진단방법및그를위한신속요소분해효소반응키트
BR0110954A (pt) 2000-05-19 2005-01-11 Otsuka Pharma Co Ltd Preparação farmacêutica para diagnóstico de infecção por helicobacter pylori
FI119571B (fi) 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
CL2008001520A1 (es) * 2008-05-26 2009-06-05 Univ Concepcion Procedimiento para detectar la virulencia de una cepa de helicobacter pylori; y kit de deteccion de dichas cepas
TWI381845B (zh) * 2009-05-21 2013-01-11 Univ Nat Taiwan 預防和治療幽門螺旋桿菌感染的組成物
KR101486999B1 (ko) 2009-07-22 2015-01-28 씨제이제일제당 주식회사 신규한 락토바실러스 플란타룸 및 이를 포함하는 조성물
US8785402B2 (en) * 2009-07-31 2014-07-22 Academia Sinica Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions
US9574002B2 (en) 2011-06-06 2017-02-21 Amgen Inc. Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
US20140206023A1 (en) * 2013-01-24 2014-07-24 Ping Gao Methods, Kits & Antibodies for Detecting Intact Fibroblast Growth Factor 21
CN104561322A (zh) * 2015-01-13 2015-04-29 石河子大学 基于幽门螺旋杆菌dna分子定量的胃癌患者生存预测及个体化随访时间评估方法
CN108350072B (zh) 2015-08-03 2022-05-24 诺华股份有限公司 治疗fgf21相关病症的方法
WO2018012941A2 (ko) 2016-07-15 2018-01-18 씨제이제일제당(주) 가스발생량이 낮은 류코노스톡 메센테로이드 cjlm119 균주 및 이를 이용한 김치의 제조방법
JP7142872B2 (ja) 2016-09-30 2022-09-28 国立研究開発法人国立がん研究センター 胃癌発症リスクの診断補助方法ならびに当該方法に利用される人工ｄｎａおよび胃癌発症リスク診断用キット
FI3538896T3 (fi) 2016-11-14 2023-08-07 Biohit Oyj Parannettu menetelmä helicobacter pylori -gastriitin ja atrofisen gastriitin sekä niihin liittyvien riskien havaitsemiseen

Also Published As

Publication number Publication date
JP2022516117A (ja) 2022-02-24
AU2019416610A1 (en) 2021-07-22
KR102637908B1 (ko) 2024-02-20
US20220064734A1 (en) 2022-03-03
WO2020139021A1 (ko) 2020-07-02
KR20200081879A (ko) 2020-07-08
AU2019416610B2 (en) 2023-06-01
TW202039861A (zh) 2020-11-01
EP3904534A4 (en) 2022-09-14
JP7374196B2 (ja) 2023-11-06
CA3125106A1 (en) 2020-07-02
EP3904534A1 (en) 2021-11-03
CN113490752A (zh) 2021-10-08
TWI754201B (zh) 2022-02-01

Similar Documents

Publication Publication Date Title
SG11202106666UA (en) Methods for rna analysis
IL289282A (en) trust mark
PL3564440T3 (pl) Pociąg do układania nawierzchni
CA194988S (en) Litter scoop
EP3381398C0 (en) MARKER POSITION IDENTIFICATION SYSTEM FOR ORTHOPEDIC SURGERY
SG11202012126UA (en) Magnetic marker
GB201911365D0 (en) Light-emitting marker particles
ITUB20152872A1 (it) SNP rs12603226 come marcatore predittivo per la NAFLD
IL289348A (en) A new diagnostic marker for pancreatic cancer
PL3946135T3 (pl) Znacznik miejsca biopsji dla ograniczonej migracji
GB201408948D0 (en) ID information for identifying an animal
ZA202202930B (en) Diagnostic chromosome marker
SG11202107005YA (en) Genetic marker for helicobacter pylori-associated disease
GB2586229B (en) Light-emitting marker
ES1214390Y (es) Sensor para marcador
GB202003510D0 (en) Genetic disease modeling
GB2576994B (en) Road marker placement apparatus
GB202306949D0 (en) Disease marker
GB201914729D0 (en) DNA marker
GB201906487D0 (en) DNA Marker
GB201820629D0 (en) Marker
GB2570969B (en) Improved location marker device
GB201804618D0 (en) Novel Marker
GB201806581D0 (en) Fluorescent Marker
GB202006286D0 (en) DNA marker